Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBPharmaceutical. 30 September 2024 India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. Generics. 30 September 2024 The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related ...
Pharmaceutical Industry News | The Pharmaletter
WEBSep 24, 2024 · Mergers and Acquisitions. The Pharma Letter M&A roundup - September 2024. Pharma dealmakers appear to have largely remained on their summer holidays in a month when none of the industry's biggest players announced acquisitions.2 October 2024. M&A activity – new inflammatory disease targets …
About The Pharma Letter | The Pharmaletter
WEBThe Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Validus Pharma gets rights to six Novartis drugs in USA
WEBNov 19, 2012 · USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired USs rights to six well-known product lines, patent protection on which has now expired, from the US subsidiary of …
BRIEF—Transpire Bio inks agreement with Recipharm
WEB15 July 2022. USA-based Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has entered into a definitive agreement with Sweden-headquartered contract development and manufacturing organization Recipharm to develop TRB …
Pharma News and Insights Podcast | The Pharmaletter
WEBJul 17, 2023 · The Pharma Letter Podcast — Episode 22 — A new way to innovate, from Flagship Pioneering. Flagship Pioneering has had an outsized impact on the sector, launching a spate of successful biotechs, including Moderna Therapeutics. Now, with Pioneering Medicines, the group hopes to shake things up again. 20 April 2023.
The path to pharma-psych innovation
WEBOct 3, 2017 · Daily roundup of key events in pharma and biotech. Monthly in-depth briefings on Boardroom appointments and M&A news. Choose from a cost-effective annual package or a flexible monthly subscription. The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on …
FDA withdraws accelerated approval for Truseltiq in …
WEBBiotechnology. 20 May 2024. The US Food and Drug Administration (FDA) announced the final withdrawal of the approval of BridgeBio Pharma (Nasdaq: BBIO) Truseltiq (infigratinib) for previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement.
BeiGene to defend patent infringement claims by Pharmacyclics
WEBBiotechnology. 19 June 2023. China-headquartered biotech BeiGene (Nasdaq: BGNE; HKEX) says it is aware that Pharmacyclics has filed a complaint against BeiGene and its US subsidiary alleging that its lead product Brukinsa (zanubrutinib) infringes a patent issued on June 13, 2023, to Pharmacyclics, a subsidiary of US pharma major AbbVie (NYSE ...
Short-acting insulin market set for growth, finds industry analyst
WEBSep 6, 2024 · The short-acting insulin market is set for substantial growth, driven by rising diabetes prevalence, technological advancements, and evolving healthcare policies, with North America expected to lead due to an aging population, increasing obesity, and a focus on diabetes education. Key players include Eli Lilly, Novo Nordisk, and Sanofi, alongside generic and biosimilar manufacturers that are ...